Key result
Ultra-high-density mapping-guided ablation eliminates recurrent VT while preserving cardiac function in ARVC.
Why the study?
Catheter ablation is beneficial for ARVC-related VT, but extensive substrate ablation may increase the risk of iatrogenic hemodynamic decompensation.
Does precise radiofrequency catheter ablation guided by ultra-high density mapping prevent VT recurrence and preserve cardiac function in a patient with ARVC?
Case Report (n=1)
Does precise radiofrequency catheter ablation guided by ultra-high density mapping prevent VT recurrence and preserve cardiac function in a patient with ARVC?
Ultra-high density mapping-guided precise ablation effectively targeted the arrhythmogenic substrate in an ARVC patient, achieving VT freedom without extensive substrate ablation that could compromise cardiac function.
May support targeted VT ablation to preserve RV function in ARVC; hypothesis-generating for ultra-high density mapping in prospective studies.
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy that often leads to ventricular dysfunction and recurrent ventricular tachycardia (VT). Catheter ablation is a beneficial treatment for ARVC-related VT, but extensive substrate ablation may increase the risk of iatrogenic hemodynamic decompensation. CASE SUMMARY: We describe a 54-year-old female ARVC patient with paroxysmal palpitations and frequent implantable cardioverter-defibrillator discharges. DISCUSSION: This case demonstrates that ultra-high density mapping-guided precise ablation can effectively target the "culprit" substrate in ARVC patients with extensive ventricular scarring, achieving a favorable balance between long-term freedom from VT and preservation of residual cardiac function. TAKE-HOME MESSAGES: Precise ablation balances efficacy and safety by ensuring long-term VT freedom and preserving residual cardiac function in ARVC patients. Comprehensive mapping techniques, including activation mapping, entrainment mapping, and isochronal late activation mapping, improve ablation accuracy.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) conducted a case report in Arrhythmogenic right ventricular cardiomyopathy (ARVC) with ventricular tachycardia (n=1). Ultra-high density mapping-guided precise catheter ablation was evaluated on Freedom from ventricular tachycardia recurrence and preservation of cardiac function. Ultra-high density mapping-guided precise ablation effectively eliminated recurrent ventricular tachycardia and preserved cardiac function in a patient with ARVC over 10 months of follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: